YTHDF2 expression was upregulated in 13 tumor cohorts in Uterine Corpus Endometrial Carcinoma (UCEC), Stomach adenocarcinoma (STAD), Lung adenocarcinoma (LUAD), Cholangio carcinoma (CHOL), Bladder Urothelial Carcinoma (BLCA) and Liver hepatocellular carcinoma (LIHC) as well. This evidence concerns the gene YTHDF2 and gastric adenocarcinoma.